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n epidermis, Ras can inﬂuence proliferation and differ-
entiation; however, regulators of epidermal Ras function
are not fully characterized, and Ras effects on growth and
differentiation are controversial. EGF induced Ras activation
in epidermal cells along with phosphorylation of the multi-
substrate docking protein Gab1 and its binding to SHP-2.
Expression of mutant Gab1
 
Y627F
 
 deﬁcient in SHP-2 binding
or dominant-negative SHP-2
 
C459S
 
 reduced basal levels of
active Ras and downstream MAPK proteins and initiated
differentiation. Differentiation triggered by both Gab1
 
Y627F
 
and SHP-2
 
C459S
 
 could be blocked by coexpression of active
Ras, consistent with Gab1 and SHP-2 action upstream of
Ras in this process. To study the role of Gab1 and SHP-2 in
Î
 
tissue, we generated human epidermis overexpressing active
Gab1 and SHP-2. Both proteins stimulated proliferation. In
contrast, Gab1
 
Y627F
 
 and SHP-2
 
C459S
 
 inhibited epidermal
proliferation and enhanced differentiation. Consistent with a
role for Gab1 and SHP-2 in sustaining epidermal Ras/MAPK
activity, Gab1
 
 
 
/
 
 
 
 murine epidermis displayed lower levels
of active Ras and MAPK with postnatal Gab1
 
 
 
/
 
 
 
 epidermis,
demonstrating the hypoplasia and enhanced differentiation
seen previously with transgenic epidermal Ras blockade.
These data provide support for a Ras role in promoting epi-
dermal proliferation and opposing differentiation and indicate
that Gab1 and SHP-2 promote the undifferentiated epidermal
cell state by facilitating Ras/MAPK signaling.
 
Introduction
 
Self-renewing stratified epithelial tissues, such as epidermis,
maintain homeostasis by balancing cellular proliferation
with postmitotic terminal differentiation. Although the factors
controlling epidermal growth and differentiation are not fully
understood, recent data supports a role for Ras GTPases in
 
this process. Constitutive expression of active Ras and its
effector Raf can trigger growth arrest and differentiation in
cultured keratinocytes (Lin and Lowe, 2001; Roper et al.,
2001). However, other prior in vitro studies report that Ras
pathway signaling supports cell proliferation and opposes
differentiation (Mainiero et al., 1997; Zhu et al., 1999).
Recent data suggests that these discrepancies could be due
to differences in Ras signal strength in cultured cells (Dajee
et al., 2002). In tissue, recent work suggests that Ras may act
in a spatially localized fashion within basal layer cells to promote
proliferative capacity and oppose differentiation (Dajee et
al., 2002). Targeting active Ras mutants to epidermis of
transgenic mice generates hyperplastic, undifferentiated epi-
dermis (Bailleul et al., 1990; Greenhalgh et al., 1993; Brown
et al., 1998; Dajee et al., 2002). Redundancy and embryonic
lethality have hindered generation of tissue deficient in all
three H, N, and K-Ras isoforms (Umanoff et al., 1995;
Johnson et al., 1997; Ise et al., 2000; Esteban et al., 2001).
However, expression of a dominant-negative Ras mutant
that lowers levels of active Ras/MAPK in epidermis leads to
premature differentiation and proliferative failure (Dajee et
al., 2002). Together, these data suggest a tentative model
in which Ras acts within epidermis to support proliferative
capacity and oppose terminal differentiation. Compelling
additional support for this model requires alterations in
nonredundant components acting either upstream or down-
stream of Ras in epidermis.
The relative importance of signaling elements controlling
Ras function and mediating its effects can vary depending
on the cell type (Shields et al., 2000). Receptors for ligands
that include growth factors and matrix proteins can activate
Ras in many settings through membrane proximal proteins
that include Shc, Grb2, and the guanine nucleotide ex-
change factor Sos (Schlessinger, 2000; Shields et al., 2000).
In epidermis, examples of such receptors implicated in Ras
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induction include certain growth factor receptor tyrosine ki-
nases and integrins (Mainiero et al., 1997; Zhu et al., 1999;
Sibilia et al., 2000). Of interest, mice with targeted deletion
of several receptors capable of activating Ras display the re-
duced epidermal proliferation seen with transgenic Ras
blockade, suggesting their potential involvement in epider-
mal Ras signaling. Examples of these receptors include the
EGF receptor (EGFR)* (Sibilia and Wagner, 1995; Thread-
gill et al., 1995) and 
 
 
 
1 integrin (Brakebusch et al., 2000).
Major effectors that initiate signaling cascades downstream
of Ras include Raf family members, phosphoinositide
3-kinases (PI3Ks), and RalGDS proteins (Shields et al.,
2000). However, the involvement of specific regulatory and
effector molecules important in Ras function, depends on
cellular setting and tissue type, and the factors important in
epidermal Ras signaling are not clearly defined.
Among proteins acting upstream of Ras are the multisub-
strate docking protein Gab1 and the SHP-2 tyrosine phos-
phatase. Gab1 is a member of a docking protein family
(Hibi and Hirano, 2000; Guy et al., 2002; Liu and Rohr-
schneider, 2002) that recruits multiple signaling proteins af-
ter binding to and phosphorylation by selected receptor ty-
rosine kinases (Holgado-Madruga et al., 1996; Weidner et
al., 1996; Lock et al., 2000). Less well characterized as an
upstream regulator of Ras function than the Shc/Grb2 pro-
teins, Gab1 appears to play a role in activation of Ras effec-
tors, including the MAPK and PI3K signaling cascades. Al-
though growth factor–driven MAPK activation can proceed
normally in Shc
 
 
 
/
 
 
 
 cells (Lai and Pawson, 2000), it is im-
paired in Gab1
 
 
 
/
 
 
 
 cells (Itoh et al., 2000; Sachs et al.,
2000). Gab1 induction of the MAPK pathway in response
to growth factors such as EGF is dependent on binding to
the SHP-2 protein tyrosine phosphatase (Cunnick et al.,
2001). SHP-2 contains two src homology (SH)2 domains at
its NH
 
2
 
 terminus and is encoded by the 
 
PTPN11
 
 gene re-
cently shown mutated in Noonan syndrome, a disease char-
acterized by facial dysmorphology, growth retardation, and
cardiac defects (Feng, 1999; Tartaglia et al., 2001). Gab1 ac-
tivates SHP-2 by targeting it to the membrane in a process
dependent on the NH
 
2
 
-terminal pleckstrin homology (PH)
domain of Gab1 (Cunnick et al., 2002). Although SHP-2
can dephosphorylate Gab1, full characterization of the sub-
strates important for SHP-2 function has not yet been ac-
complished (Yu et al., 2002). Gab1 and SHP-2 knock-out
mice die during embryogenesis, hindering the study of adult
tissues null for these proteins (Saxton et al., 1997; Itoh et al.,
2000; Sachs et al., 2000). However, analysis of in utero and
chimeric tissue suggests that Gab1 and SHP-2 play a role in
the morphogenesis of epithelial tissues (Qu et al., 1999; Itoh
et al., 2000). The degree to which these proteins influence
epidermal growth and differentiation through proteins such
as Ras is currently unknown.
Here, we provide evidence supporting a role for Gab1
and SHP-2 in promoting Ras/MAPK signaling to enhance
epidermal cell proliferation and oppose differentiation. In
 
epidermal cells, overexpression of wild-type Gab1 and
SHP-2 extends the duration of MAPK activation in re-
sponse to EGF. In contrast, dominant-negative Gab1 and
SHP-2 mutants reduce endogenous basal levels of active
Ras and MAPK and induce differentiation, a process that
can be reversed by coexpression of active Ras. In vivo, dis-
ruption of Gab1 function in Gab1
 
 
 
/
 
 
 
 postnatal epidermis
obtained by embryo grafting and in tissue expressing domi-
nant-negative Gab1 and SHP-2 leads to decreased prolifera-
tion and enhanced differentiation. Consistent with this,
 
*Abbreviations used in this paper: E, embryonic day; EGFR, EGF receptor;
IGF, insulin-like growth factor-1; PDGF, platelet-derived growth factor;
PH, pleckstrin homology; PI3K, phosphoinositide 3-kinase; SH, src
homology.
Figure 1. Selective induction of Gab1 tyrosine phosphorylation 
and binding to SHP-2 in normal epidermal cells by EGF. (a) EGF 
selectively activates Ras/MAPK in primary human keratinocytes. 
Cells starved in minimal medium for 20 h were treated with EGF, 
IGF, or PDGF at the concentrations shown. The top panel represents 
a pan-Ras immunoblot of extracts after GST-RafBD pull-down to 
isolate only GTP-bound active Ras. Densitometric quantitations of 
the levels of active Ras and MAPK were proteins normalized to total 
MAPK loading control and are noted below each corresponding 
band. The bottom three panels represent immunoblots with the 
pan-Ras, phosphorylated ERK1/ERK2 MAPK, or total ERK1/ERK2 
MAPK antibodies noted at the left of each row. (b) EGF selectively 
enhances Gab1 tyrosine phosphorylation and binding to SHP-2. 
Extracts of primary epidermal cells treated with EGF, IGF, or PDGF 
were immunoprecipitated with antibodies to either Gab1 (Gab1 IP) 
or SHP-2 (SHP-2 IP) and then immunoblotted with antibodies to 
Gab1, SHP-2, and phosphotyrosine (pTyr). The EGF-enhanced band 
recognized on pTyr blotting corresponds to Gab1. (c) Pharmacologic 
blockade of EGFR function diminishes active Ras/MAPK, Gab1 
tyrosine phosphorylation, and binding to SHP-2. The EGFR-selective 
kinase inhibitor PD151035 and the PDGFR-selective inhibitor 
AG1295 were incubated with normal epidermal cells grown in 
complete medium. The levels of active Ras were determined by 
GST-RafBD pull-down followed by immunoblotting with pan-Ras 
antibodies and immunoblotting with antibodies to total Ras along 
with total and active MAPK. Extracts were also immunoprecipitated 
with antibodies to Gab1 and SHP-2 then immunoblotted with 
antibodies to Gab1, SHP-2, and pTyr. 
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Gab1
 
 
 
/
 
 
 
 epidermis displays diminished levels of active Ras
and MAPK. These data indicate that Gab1 and SHP-2
function as nonredundant positive regulators of epidermal
Ras function to promote cell proliferation and oppose ter-
minal differentiation.
 
Results
 
Selective induction of Gab1 tyrosine phosphorylation 
and binding to SHP-2 in normal epidermal cells by EGF
 
Although several growth factor receptors are expressed in
stratified epithelial tissues, their relative ability to activate
Ras and its effectors such as MAPK in epidermal cells is
not fully characterized. To address this, we examined levels
of activated GTP-bound Ras and phosphorylated active
ERK1/ERK2 MAPKs in primary human keratinocytes
treated with three growth factors whose receptors have been
implicated in epidermal homeostasis, EGF (Sibilia and
Wagner, 1995; Threadgill et al., 1995), insulin-like growth
factor-1 (IGF) (Liu et al., 1993), and platelet-derived
growth factor (PDGF) (Soriano, 1997). EGF, but not IGF
or PDGF, led to a dose-dependent increase in levels of active
Ras and MAPK (Fig. 1 a). We next studied the effect of
these growth factors on the tyrosine phosphorylation of
Gab1 and its binding to SHP-2. EGF, but not IGF or
PDGF, led to both increased tyrosine phosphorylation of
Gab1 and binding to SHP-2 (Fig. 1 b), suggesting a selective
effect of EGF on Ras/MAPK activation mediated by Gab1
and SHP-2. Consistent with this, inhibitors specific for
EGFR but not PDGFR lowered basal levels of active Ras
and MAPK and decreased both Gab1 tyrosine phosphoryla-
tion and Gab1–SHP-2 binding in cells (Fig. 1 c). Thus, in
epidermal cells EGF appears capable of activating Gab1,
SHP-2, and Ras/MAPK.
 
Gab1 binding to functional SHP-2 facilitates membrane 
localization of Gab1–SHP-2 and Ras/MAPK activation
 
Gab1 binding to functional SHP-2 has been shown to be
important for MAPK activation in several cell types (Cun-
nick et al., 2001, 2002). However, the importance of these
Figure 2. Interaction between functional 
Gab1 and SHP-2 in epidermal cells. 
(a) Gab1 and SHP-2 localize to the 
plasma membrane in keratinocytes 
treated with EGF after 20 h of starvation 
in minimal medium. Note that Gab1 
(green) localizes to the cell perimeter in 
response to EGF and that SHP-2 (red) 
fails to do so in the presence of the 
Gab1
Y627F mutant defective in binding to 
SHP-2. Membrane localization denoted 
with arrows. (b) Quantitation of the 
percentage of cells with SHP-2 membrane 
localization in three independent 
transductions after EGF treatment. 
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processes in facilitating activation of Ras and MAPK in nor-
mal epithelial cells has not been studied. In keratinocytes,
both Gab1 and SHP-2 localize to the cell perimeter in re-
sponse to EGF (Fig. 2). SHP-2 redistribution is blocked by
expression of the Gab1
 
Y627F
 
 mutant defective in SHP-2
binding (Cunnick et al., 2001), indicating that SHP-2
membrane recruitment is dependent on Gab1 in epidermal
cells (Fig. 2). Since membrane localization of SHP-2 is suffi-
cient for MAPK activation in other cell types (Cunnick et
al., 2002), we examined whether its disruption by expression
of Gab1
 
Y627F
 
 decreased basal levels of active Ras and MAPK
in the absence of growth factor stimulation. Gab1
 
Y627F
 
 led to
a decrease in constitutively present levels of GTP-bound ac-
tive Ras and phosphorylated MAPK in keratinocytes (Fig. 3
a). Suppression of basal levels of active Ras/MAPK was also
seen with a catalytically inactive dominant-negative SHP-2
mutant, SHP-2
 
C459S
 
 (Fig. 3 b). Consistent with prior find-
ings that inactive SHP-2 remains bound to its phosphory-
lated substrates, immunoprecipitation of SHP-2 in cells
expressing SHP-2
 
C459S
 
 demonstrated an increase in tyrosine-
phosphorylated proteins bound to inactive SHP-2 (Fig. 3 c),
including p90 and PZR (Zhao and Zhao, 1998; Shi et al.,
2000). Therefore, physical association of Gab1 with a cata-
lytically active SHP-2 facilitates Ras/MAPK activation in
epidermal cells.
To examine the duration of MAPK activation as a func-
tion of Gab1 and SHP-2 in primary epidermal cells, we de-
termined the kinetics of increased MAPK phosphorylation
in response to high dose EGF stimulation in cells transduced
with retrovectors encoding Gab1, SHP-2, Gab1
 
Y627F
 
, SHP-
2
 
C459S
 
, and LacZ control. Gab1 and SHP-2 overexpression
prolonged the persistence of increased MAPK phosphoryla-
tion after strong EGF stimulation of cells grown initially in
minimal medium without growth factors for 20 h; mutant
Gab1 and SHP-2 proteins did not (Fig. 4). Interestingly,
dominant-negative Gab1 and SHP-2 fail to block MAPK
activation in response to high strength EGF stimulation,
suggesting that their capacity for inhibition is confined to
lower levels of growth factor action (Fig. 4). These data are
consistent with findings in embryonic fibroblasts (Itoh et al.,
2000; Shi et al., 2000) that Gab1 and SHP-2 act to sustain
MAPK pathway signaling.
 
Gab1 and SHP-2 affect differentiation gene expression 
in epidermal cells
 
If Ras/MAPK regulation is a major effect of Gab1 and SHP-2
proteins, then altering their function should affect epider-
mal growth and differentiation. These processes can be dra-
matically influenced by changes in epidermal Ras activity
where continual Ras function has been proposed as neces-
sary to prevent differentiation and sustain proliferative ca-
pacity (Dajee et al., 2002). Expression of dominant-negative
Gab1
 
Y627F
 
 and SHP-2
 
C459S
 
 but not wild-type proteins in-
duced epidermal differentiation markers in the absence of
other stimuli (Fig. 5 a). Differentiation triggered by disrup-
tion of Gab1 and SHP-2 function can be blocked by coex-
pression of active Ras (Fig. 5 b), consistent with a process in
which Gab1 and SHP-2 effects on epidermal differentiation
reside upstream of Ras. To study Gab1 and SHP-2 effects
on differentiation in vivo, we expressed wild-type Gab1 and
SHP-2 along with dominant-negative Gab1
 
Y627F
 
 and SHP-
2
 
C459S
 
 in primary human keratinocytes. We then used these
cells in a well-established approach (Medalie et al., 1996;
Robbins et al., 2001) to regenerate transgenic human skin
on immune-deficient mice. Epidermis expressing wild-type
Gab1 and SHP-2 displayed slightly decreased differentia-
tion marker staining; however, Gab1
 
Y627F
 
 and SHP-2
 
C459S
 
-
expressing epidermis displayed markedly enhanced levels of
these proteins (Fig. 6 a). These data suggest that Gab1 and
SHP-2 influence epidermal differentiation in vivo.
 
Gab1 and SHP-2 overexpression alters epidermal 
proliferation in vivo
 
In addition to opposing differentiation, Ras/MAPK signal-
ing may play an important role in promoting cell prolifera-
Figure 3. Effect of Gab1 and SHP-2 on levels of active Ras and 
MAPK in epidermal cells. (a) The SHP-2 binding-deficient dominant-
negative Gab1
Y627F mutant decreases levels of active Ras and 
MAPK in epidermal cells. Levels of active Ras and MAPK were 
determined by GST-RafBD pull-down and immunoblotting in primary 
human keratinocytes transduced at high efficiency with retroviral 
expression vectors for wild-type human Gab1 and Gab1
Y627F along 
with lacZ transduction control. Cells were grown in complete 
medium without additional growth factor stimulation. All Gab1 
constructs contained a myc epitope tag used to confirm comparable 
levels of expression and for immunoprecipitation and immunoblotting 
with antibodies to SHP-2 (myc IP → SHP-2 IB). (b) The dominant-
negative SHP-2
C459S mutant decreases levels of active Ras and 
MAPK in epidermal cells. Extracts from primary human keratinocytes 
transduced with retovectors encoding wild-type SHP-2, SHP-2
C459S, 
and lacZ control were assessed for levels of active Ras, MAPK, 
and SHP-2. (c) SHP-2
C459S binds to increased amounts of tyrosine-
phosphorylated proteins in epidermal cells. Extracts from primary 
human keratinocytes transduced with retovectors encoding wild-type 
SHP-2, SHP-2
C459S, and lacZ control were immunoprecipitated 
with antibodies to SHP-2. pTyr immunoblotting demonstrates 
increased association with tyrosine-phosphorylated proteins by 
phosphatase-defective SHP-2
C459S. 
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tion in epidermis (Mainiero et al., 1997; Zhu et al., 1999;
Dajee et al., 2002). To determine if altering Gab1 and SHP-2
function impacts epidermal proliferation, we assessed cell di-
vision in transgenic human epidermis. After 4 wk, expres-
sion of wild-type Gab1 and SHP-2 led to mild epidermal
hyperplasia and an increase in the number of actively divid-
ing cells in vivo. In contrast, Gab1
 
Y627F
 
 and SHP-2
 
C459S
 
 ex-
pression over this period suppressed active cell division and
produced epidermal hypoplasia (Fig. 6, a and b). Therefore,
Gab1 and SHP-2 can promote epidermal proliferation and
dominant interference with their function leads to decreased
cell division in vivo.
 
Altered Ras/MAPK activity and epidermal growth and 
differentiation in postnatal Gab1
 
   
 
 tissue
 
In studying the effects of loss of function of Gab1 and
SHP-2, genetic ablation studies are an important comple-
ment to expression of transdominant molecules. Shc/Grb2-
mediated signal transmission from EGFR to Ras may oper-
ate in a partially distinct manner from that mediated by
SHP-2 (Shi et al., 2000), and the relative degree to which
these two mechanisms function in epidermis is unknown. If
Gab1/SHP-2 function is important in maintaining physio-
logic levels of active Ras, then its disruption should lead to
diminished levels of GTP-bound Ras. To test this, we ana-
lyzed active Ras levels in epidermis isolated from Gab1
 
 
 
/
 
 
 
embryos. Levels of active Ras and its downstream target
MAPKs were decreased in Gab1
 
 
 
/
 
 
 
 epidermis compared
with Gab1
 
 
 
/
 
 
 
 control (Fig. 7 a). Thus, Gab1 plays a nonre-
dundant role in positively modulating Ras/MAPK activity
in epidermis.
In agreement with a role for regulation of epidermal Ras
function by Gab1 and SHP-2, initial studies of embryonic
and chimeric Gab1- and SHP-2–deficient tissue suggest a
potential role for both proteins in epithelial morphogenesis
(Qu et al., 1999; Itoh et al., 2000). However, Gab1
 
 
 
/
 
 
 
 and
Figure 4. Gab1 and SHP-2 expression 
prolongs the duration of elevated active 
MAPK levels after EGF stimulation. 
(a) Levels of total and active MAPK 
were determined in primary human 
keratinocytes transduced with 
retrovectors expressing the proteins noted 
over each panel. Cells were starved of 
growth factors for 20 h and then exposed 
to high dose EGF stimulation at 100 ng/ml 
for the durations shown. Densitometric 
quantitation was normalized to total 
MAPK loading control for each lane and 
is shown below each corresponding 
band. Data is representative of three 
independent time course series of 
experiments. Wt, wild-type. (b) Graphic 
representation of active MAPK levels 
shown in Fig. 4 A over time in cells 
expressing wild-type and mutant Gab1 
and SHP-2 proteins.
Figure 5. Effects of altered Gab1 and 
SHP-2 function on differentiation of 
epidermal cells. (a) Expression of 
dominant-negative Gab1 and SHP-2 
induces expression of differentiation 
markers in primary epidermal cells. 
Immunoblots of cell extracts prepared 
from cells expressing wild-type or mutant 
Gab1 and SHP-2 using antibodies to the 
differentiation markers keratin 1 and involucrin are shown. Actin loading control for each lane is shown in the bottom panel. (b) Differentiation 
induced by dominant-negative Gab1 and SHP-2 is blocked by expression of active Ras. Immunoblots of extracts from cells expressing either 
Gab1
Y627F or SHP-2
C459S alone or in combination with active Ras
G12V are shown. 
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SHP-2
 
 
 
/
 
 
 
 mice die by embryonic day (E)17.5 and E10.5,
respectively, hindering phenotypic assessment in postnatal
epidermal tissue (Saxton et al., 1997; Itoh et al., 2000). To
study the effects of Gab1 deletion in developmentally ma-
ture epidermis, we grafted skin from E17.5 Gab1
 
 
 
/
 
 
 
 mice
along with normal control to immune-deficient mice. 3 wk
following grafting after epidermal maturation and the onset
of the first anagen hair cycle, Gab1
 
 
 
/
 
 
 
 epidermis displayed
marked hypoplasia, suggesting a defect in epidermal prolif-
eration (Fig. 7 b). Although basal levels of proliferation are
elevated overall in postnatal murine tissue at this time point
compared with regenerated human skin, Gab1
 
 
 
/
 
 
 
 epidermis
displayed a mitotic index of less than half of normal litter-
mate tissue (Fig. 7 c). In addition to proliferative deficits,
Gab1
 
 
 
/
 
 
 
 epidermis displayed enhanced expression of differ-
entiation markers which in some cases displayed premature
expression down to the basal layer (Fig. 7 b), similar to find-
ings seen with epidermis overexpressing dominant-negative
SHP-2. Similar findings of lesser magnitude were also ob-
served with E17.5 Gab1
 
 
 
/
 
 
 
 skin (Fig. S2 available at http://
www.jcb.org/cgi/content/full/jcb.200205017/DC1). The
poor growth of Gab1
 
 
 
/
 
 
 
 keratinocytes in culture precluded
studies to examine the ability of both wild-type and SHP-2
binding-deficient Gab1 to restore Ras/MAPK activation.
However, recent work (unpublished data) has demonstrated
that introduction of wild-type but not Gab1
 
Y627F
 
 into
Gab1
 
 
 
/
 
 
 
 fibroblast cell lines rescues Ras/MAPK activation.
These findings indicate that Gab1 plays a nonredundant
role in supporting proliferation and opposing differentiation
in the epidermis.
 
Discussion
 
Here, we have shown that altering the function of Gab1
and SHP-2 modulates the levels of active Ras/MAPK in
epidermal cells in association with changes in growth and
differentiation. Differentiation induced by dominant-nega-
tive Gab1 and SHP-2 mutants is abolished by active Ras,
indicating that Gab1/SHP-2 actions in this process may re-
side upstream of Ras, consistent with prior biochemical
data (Itoh et al., 2000; Shi et al., 2000; Cunnick et al.,
2002). Duration of MAPK signaling is important in gener-
ating different biologic outcomes, but major cell type dif-
ferences exist in signaling by Ras and its effectors (Shields et
al., 2000). We observed that Gab1 and SHP-2 overexpres-
sion prolong the persistence of active epidermal MAPK in
Figure 6. Overexpression of Gab1 and SHP-2 in vivo alters epidermal 
proliferation and differentiation. (a) Cells transduced with retrovectors 
expressing either wild-type Gab1, wild-type SHP-2, or the Gab1
Y627F 
and SHP-2
C459S dominant-negative mutants and lacZ control were 
used to regenerate human epidermis on immune-deficient mice. 
Histology and immunostaining for differentiation and proliferation 
markers is shown. Note the mild hyperplasia of Gab1- and SHP-2–
expressing tissue and the hypoplasia of epidermis-expressing Gab1
Y627F 
and SHP-2
C459S. Note also the mild decrease in differentiation marker 
gene expression in Gab1- and SHP-2–expressing epidermis and the 
strong increase differentiation marker expression within tissue-
expressing Gab1
Y627F and SHP-2
C459S. The dotted line denotes the 
basement membrane zone. Bars, 50  m. (b) Epidermal proliferation is 
altered by Gab1 and SHP-2 expression. Data represents the number 
of Ki-67( ) cells per 100  m of basement membrane length from 
three independently analyzed tissue specimens   SD. 
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response to EGF stimulation, consonant with prior obser-
vations in fibroblasts and transformed cell lines. However,
dominant-negative Gab1 and SHP-2 fail to block MAPK
induction in response to strong EGF stimulation, under-
scoring the contribution of other elements such as Sos/
Grb2/Shc in this setting.
Combined with induction of differentiation by Gab1/
SHP-2 inhibition, these findings suggest that Gab1 and
SHP-2 may inhibit differentiation by contributing to sus-
tained Ras/MAPK signaling in epidermal cells. In this re-
gard, the role of Gab1/SHP-2 may be to facilitate basal lev-
els of Ras/MAPK activation in response to factors such as
EGF, whereas other proteins, such as Sos/Grb2/Shc, medi-
ate responses to strong growth factor stimulation. In agree-
ment with this possibility is the recent observation that both
dominant-negative Ras and pharmacologic inhibition of
MEK/MAPK triggers keratinocyte differentiation in the ab-
sence of other stimuli (Dajee et al., 2002). These data thus
suggest an important role for Gab1 and SHP-2 as necessary
in maintaining the undifferentiated state within the epider-
mis through promotion of Ras/MAPK signaling.
Precise roles for specific receptor tyrosine kinases in con-
trolling growth and differentiation in the epidermis have
not been fully defined, and we believe it is unlikely that a
Figure 7. Altered Ras/MAPK activity, epidermal growth, and differentiation in postnatal 
Gab1
 /  tissue. (a) Levels of active Ras and MAPK are reduced in Gab1
 /  epidermis in vivo. 
Extracts were prepared from epidermal tissue isolated at E17.5 from Gab1
 /  embryos and 
Gab1
 /  siblings and the levels of active GTP-bound Ras and phosphorylated MAPK were 
determined by GST-RafBD pull-down assay and immunoblotting. (b) Phenotype of postnatal 
Gab1
 /  epidermis. Skin was harvested at E17.5 from Gab1
 /  embryos and Gab1
 /  
littermates and grafted to immune-deficient mice. Histology and immunostaining for 
differentiation and proliferation markers are shown in skin harvested 3 wk later after epidermal 
maturation and the onset of the first anagen hair cycle. Note the striking hypoplasia, 
enhanced differentiation marker gene expression, and decrease in Ki-67( ) cells in Gab1
 /  
epidermis compared with normal control; overall mitotic activity is normally elevated in 
postnatal murine tissue. Involucrin, K10, and Ki-67 staining (green); the basement membrane 
zone marker  6 integrin (red). Bars, 30  m. (c) Number of Ki-67( ) cells per 100  m of 
basement membrane length from three independently analyzed tissue specimens   SD.110 The Journal of Cell Biology | Volume 159, Number 1, 2002
single receptor such as EGFR is the sole control point for
these processes. In epidermal cells, we observed that Gab1
tyrosine phosphorylation and binding to SHP-2 along with
Ras activation is enhanced in response to EGF and can be
blocked by a selective inhibitor of EGFR function. In addi-
tion to EGFR, integrins such as  1 appear to promote
epidermal proliferation and inhibit differentiation (Brake-
busch et al., 2000; Haase et al., 2001), although charac-
terization of integrin effects in isolation from their impor-
tant roles in adhesion requires further study. Similar to
EGFR, specific integrins may rely at least in part on Ras for
intracellular signal transmission (Mainiero et al., 1997; Zhu
et al., 1999); however, a potential role for Gab1–SHP-2 in
integrin signaling has not been systematically examined.
SHP-2 does not appear to transmit signal from EGFR to
Ras through the better characterized Shc, Grb2, and Sos
pathways, but evidence suggests that Gab1 itself may (Shi et
al., 2000). Additional studies are required to examine the
relative contributions of each of these elements to epider-
mal growth and differentiation.
Our data suggest that a mechanistic process involving
EGFR, Gab1, SHP-2, Ras, Raf, MEK, and MAPK may op-
erate in a manner that is spatially confined to the basal layer
of this stratified epithelium. Consistent with this possibility,
EGFR, Ras, and active MAPK protein are localized in the
undifferentiated basal layer of epidermis (Fukuyama and
Shimizu, 1991; Dajee et al., 2002) (Fig. S1 available at http:
//www.jcb.org/cgi/content/full/jcb.200205017/DC1). Cur-
rently, available antibodies to Gab1 and SHP-2 do not func-
tion well in tissue immunostaining as judged by failure to
give specific signals with skin tissue with either absence or
overexpression of these proteins (unpublished data). How-
ever, we have shown here that both of these proteins are ex-
pressed in undifferentiated epidermal cells, and it has been
demonstrated previously that the Gab1 promoter is active in
the basal layer of epidermis (Itoh et al., 2000). Since the
basal epidermal layer houses the proliferative pool of undif-
ferentiated cells responsible for epidermal self-renewal, such
a model of spatially localized action would predict that aug-
menting the function of components of this pathway in this
location would enhance epidermal proliferation. The cur-
rent work indicates that this prediction holds true for Gab1
and SHP-2. We and others have reported similar effects for
Ras (Bailleul et al., 1990; Greenhalgh et al., 1993; Brown et
al., 1998; Dajee et al., 2002).
Regarding other components of the Ras/MAPK pathway,
epidermal expression of active MEK1 (Haase et al., 2001)
also augments proliferation and inhibits differentiation. In
further support of our model, interference with function of
these proteins leads to diminished proliferation and epider-
mal hypoplasia. Examples of this include the observations
reported here for Gab1 and SHP-2 and previously described
EGFR
 /  mice (Sibilia and Wagner, 1995; Threadgill et al.,
1995) and transgenic mice overexpressing a dominant-nega-
tive Ras in epidermis (Dajee et al., 2002). In the case of the
latter, hypoproliferation was only observed when dominant-
negative Ras was targeted to the basal layer and not supra-
basal layer cells, underscoring the spatial localization and
basal layer cell intrinsic nature of this process. Together,
these data support a model in which epidermal proliferation
is influenced by the action of a signaling process involving
EGFR, Gab1, SHP-2, Ras, Raf, MEK, and MAPK whose
spatial localization helps divide epidermis into a prolifera-
tive, undifferentiated compartment and a postmitotic differ-
entiating compartment.
Materials and methods
Cell culture and gene transfer
Coding sequences for human Gab1 (Yart et al., 2001), SHP-2 (Zhao and
Zhao, 1998), and H-Ras
G12V were subcloned into the HindIII/NotI, BamHI/
HindIII, and BamHI/NotI sites of LZRS vector (Kinsella and Nolan, 1996),
respectively. Primary human keratinocytes were isolated and grown as de-
scribed (Choate et al., 1996). Retrovirus was prepared in human 293T
packaging cells as described (Kinsella and Nolan, 1996; Deng et al.,
1998). Primary keratinocytes underwent retroviral transduction at a multi-
plicity of infection of 15 without drug selection (Robbins et al., 2001).
Growth factors or receptor inhibitors were incubated with primary human
keratinocytes for 5 and 20 min, respectively, before extract preparation at
the following concentrations: EGF (10 ng or 100 ng/ml; Sigma-Aldrich), IGF
(100 ng/ml; Sigma-Aldrich), PDGF (100 ng/ml; Sigma-Aldrich), PD153035
(250 nM; Calbiochem), and AG1295 (10  M; Calbiochem).
Protein expression
Keratinocytes were lysed in lysis buffer (25 mM Hepes, pH 7.5, 150 mM
NaCl, 1% NP-40, 10 mM MgCl2, 1mM EDTA, 10% glycerol) with protease
inhibitors and denatured by boiling with  20  g of extract loaded per
lane. Antibodies were obtained from the following sources: Gab1 and pTyr
(Upstate Biotechnology), SHP-2 and c-myc (Santa Cruz Biotechnology,
Inc.), pan-Ras (Oncogene Research Products), involucrin and human kera-
tin 1 (Babco), and phospho-MAPK and MAPK (Cell Signaling). Immuno-
blots were stripped and reprobed with antibodies to  -actin (Santa Cruz
Biotechnology, Inc.) as an additional control for loading and extract qual-
ity. Results were quantitated using a GS-710 Calibrated Imaging Densitom-
eter (Bio-Rad Laboratories), and data were normalized to loading control
for the same sample lane.
Immunoprecipitation and quantitation of active Ras
500  g of cell lysate protein was precleared with equilibrated protein A
beads (Sigma-Aldrich) and incubated with anti-Gab1 or anti–SHP-2 anti-
body for 4 h. Immune complexes were precipitated with protein A/G
beads (Sigma-Aldrich) and subjected to immunoblotting. The active Ras-
GTP pull-down assay was performed under nonsaturated conditions as
described (de Rooij and Bos, 1997). Briefly, 150  l Escherichia coli GST-
RBD lysate was incubated with 30  l glutathione-sepharose beads (Amer-
sham Biosciences) at room temperature for 30 min with shaking. After
washing the sepharose beads, 500  g of epidermal cell extract was added
at 4 C for 1 h with shaking. After three washes, the samples were sub-
jected to 12% SDS-PAGE. Levels of active Ras protein were detected by a
pan-Ras antibody (Oncogene Research Products) and quantitated as
noted above.
Histology and immunofluorescence
Genetically engineered human epidermis was regenerated on CB.17 scid/
scid mice after gene transfer as described (Choate et al., 1996; Robbins et
al., 2001). E17.5 Gab1
 /  and wild-type embryonic mice skin was grafted
following the same procedure. Four mice were grafted and analyzed per
group. At 3–5 wk after grafting, skin tissue was excised and subjected to
analysis. For histological examination, skin tissue was fixed in 4%
paraformaldehyde overnight, embedded in paraffin, and 5- m sections
were stained with hematoxylin and eosin. For immunostaining, 5- m skin
cryosections were allowed to air dry for 30 min and permeabilized with
cold acetone for 10 min. Sections were blocked with 10% horse serum for
1 h and treated with the primary antibody for 1 h at room temperature.
Slides were then washed three times with PBS and incubated for 30 min
with secondary antibodies. After three washes with PBS, slides were
mounted in Vectashield (Vector Laboratories) and examined under a ZEISS
100M Axiovert microscope. The following panel of antibodies was used in
immunostaining: anti–human K1, anti–mouse K10, and anti–mouse in-
volucrin (Babco); anti–human Ki-67 (LabVision); anti–mouse Ki-67 (Dako);
anti–integrin  6 (Chemicon); FITC-conjugated goat anti–mouse IgG, FITC-
conjugated goat anti–rabbit IgG and FITC-conjugated rabbit anti–rat IgG
(Sigma-Aldrich); and Cy3-conjugated goat anti–rat IgG (Jackson Immu-
noResearch Laboratories).Gab1/SHP-2 epidermal regulation | Cai et al.  111
Online supplemental material
Figs. S1 and S2 are available at http://www.jcb.org/cgi/content/full/
jcb.200205017/DC1. Fig. S1 shows that Ras and EGFR are expressed in
the undifferentiated epidermal basal layer. Immunostaining of normal hu-
man epidermal tissue with antibodies to Ras and EGFR (green) and the su-
perbasal layer differentiation marker involucrin (red) are shown; the dotted
line denotes the basement membrane zone. Fig. S2 shows the histology
and immunostaining of proliferation marker Ki-67 and differentiation
marker keratin 10 of Gab1 E17.5 embryo skin.
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